» Articles » PMID: 26307584

BMP-7 Induces Adult Human Pancreatic Exocrine-to-Endocrine Conversion

Overview
Journal Diabetes
Specialty Endocrinology
Date 2015 Aug 27
PMID 26307584
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The exocrine pancreas can give rise to endocrine insulin-producing cells upon ectopic expression of key transcription factors. However, the need for genetic manipulation remains a translational hurdle for diabetes therapy. Here we report the conversion of adult human nonendocrine pancreatic tissue into endocrine cell types by exposure to bone morphogenetic protein 7. The use of this U.S. Food and Drug Administration-approved agent, without any genetic manipulation, results in the neogenesis of clusters that exhibit high insulin content and glucose responsiveness both in vitro and in vivo. In vitro lineage tracing confirmed that BMP-7-induced insulin-expressing cells arise mainly from extrainsular PDX-1(+), carbonic anhydrase II(-) (mature ductal), elastase 3a (acinar)(-) , and insulin(-) subpopulations. The nongenetic conversion of human pancreatic exocrine cells to endocrine cells is novel and represents a safer and simpler alternative to genetic reprogramming.

Citing Articles

Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors.

Karakose E, Wang X, Wang P, Carcamo S, Demircioglu D, Lambertini L Cell Rep Med. 2024; 5(12):101832.

PMID: 39626675 PMC: 11722108. DOI: 10.1016/j.xcrm.2024.101832.


The Influence of BMP6 on Serotonin and Glucose Metabolism.

Milesevic M, Matic Jelic I, Rumenovic V, Ivanjko N, Vukicevic S, Bordukalo-Niksic T Int J Mol Sci. 2024; 25(14).

PMID: 39063084 PMC: 11276723. DOI: 10.3390/ijms25147842.


Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".

Karpov D, Sosnovtseva A, Pylina S, Bastrich A, Petrova D, Kovalev M Int J Mol Sci. 2023; 24(24).

PMID: 38139149 PMC: 10743607. DOI: 10.3390/ijms242417320.


Bone morphogenetic protein-7 attenuates pancreatic damage under diabetic conditions and prevents progression to diabetic nephropathy via inhibition of ferroptosis.

Song S, Han D, Park K, Um J, Kim S, Ku M Front Endocrinol (Lausanne). 2023; 14:1172199.

PMID: 37293506 PMC: 10244744. DOI: 10.3389/fendo.2023.1172199.


Reprogramming-Evolving Path to Functional Surrogate β-Cells.

Kalo E, Read S, Ahlenstiel G Cells. 2022; 11(18).

PMID: 36139388 PMC: 9496933. DOI: 10.3390/cells11182813.


References
1.
Bonner-Weir S, Inada A, Yatoh S, Li W, Aye T, Toschi E . Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans. 2008; 36(Pt 3):353-6. DOI: 10.1042/BST0360353. View

2.
Russ H, Bar Y, Ravassard P, Efrat S . In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes. 2008; 57(6):1575-83. DOI: 10.2337/db07-1283. View

3.
Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton D . In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008; 455(7213):627-32. PMC: 9011918. DOI: 10.1038/nature07314. View

4.
Gannon M, Gamer L, Wright C . Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev Biol. 2002; 238(1):185-201. DOI: 10.1006/dbio.2001.0359. View

5.
Jiang F, Stanley E, Gonez L, Harrison L . Bone morphogenetic proteins promote development of fetal pancreas epithelial colonies containing insulin-positive cells. J Cell Sci. 2002; 115(Pt 4):753-60. DOI: 10.1242/jcs.115.4.753. View